Our Efforts to Develop a COVID-19 Vaccine
GET TO KNOW DR. ANNALIESA ANDERSON, HEAD OF BACTERIAL VACCINES
PROFESSOR JOE SCHMITT TALKS TICK-BOURNE ENCEPHALITIS
HOW ARE VACCINES DEVELOPED?
Find a Trial
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
COVID-19 AND CANCER
WHAT YOU NEED TO KNOW ABOUT COVID-19
Latest News
-Abrocitinib met all key endpoints, demonstrating statistically superior improvements in skin clearance, disease extent and severity, and itch compared to placebo- -Safety profile consistent with other pivotal studies of abrocitinib reported to date- Pfizer Inc. (NYSE: PFE) announced today that JAMA Dermatology has published complete results from the second Phase 3 monotherapy pivotal study (JADE MONO-2) of abrocitinib, an investigational oral once-daily Janus kinase 1 (JAK1) inhibitor, in…